Nörolojik Hastalıklar ve Sirkadiyen Ritim
Özet
Sirkadiyen ritim, canlıların bir günlük zaman dilimi içerisindeki hücresel ve sistemik fonksiyonlarını düzenleyen biyolojik bir zamanlama sistemidir. Bu sistemin bozulması ile uyku eksikliği; Alzheimer, Parkinson, inme, epilepsi, multipl skleroz (MS), migren, küme baş ağrısı ve nöropatik ağrı gibi birçok nörolojik hastalığın patofizyolojisinde kritik rol oynamaktadır. Alzheimer hastalarında sirkadiyen ritim bozukluğu amiloid beta ve tau birikimini artırırken; Parkinson hastalarında dopaminerjik sistem ve melatonin salınım mekanizmalarını olumsuz etkileyerek motor ve non-motor semptomları şiddetlendirir. İnme sonrası uyku deprivasyonu, glutamat seviyelerini artırıp eksitotoksisiteye ve nöronal rekonneksiyonun inhibisyonuna yol açarak beyin hasarını kötüleştirir. Epilepside nöbet eşiğini düşürerek membran eksitabilitesini artıran uyku deprivasyonu, MS hastalarında ise oligodendrosit prekürsör hücrelerin farklılaşmasını baskılayarak miyelin protein sentezini olumsuz etkiler ve nöro-immun disregülasyonu tetikler. Migren ve küme baş ağrılarında melatonin düzeylerinin azalması ve suprakiazmatik nükleus kontrolünün zayıflaması nokturnal atakların sıklığını artırır. Benzer şekilde nöropatik ağrıda sirkadiyen ritmin bozulması, glutamat konsantrasyonunu artırıp opioid nosiseptif sistemi stimüle ederek ağrı hassasiyetini üst seviyeye çıkarır. Sonuç olarak, sirkadiyen ritim nörolojik hastalıkların hücresel ve moleküler süreçlerini modüle eden hayati bir faktördür.
Circadian rhythm is a biological timing system that regulates cellular and systemic functions of living beings within a twenty-four-hour period. Disruption of this system and sleep deprivation play a critical role in the pathophysiology of many neurological diseases such as Alzheimer's, Parkinson's, stroke, epilepsy, multiple sclerosis (MS), migraine, cluster headache, and neuropathic pain. While circadian rhythm disturbance increases amyloid beta and tau accumulation in Alzheimer's patients, it exacerbates motor and non-motor symptoms in Parkinson's by adversely affecting the dopaminergic system and melatonin secretion mechanisms. Post-stroke sleep deprivation worsens brain damage by increasing glutamate levels, leading to excitotoxicity and inhibition of neuronal reconnection. Sleep deprivation, which lowers the seizure threshold by increasing membrane excitability in epilepsy, negatively affects myelin protein synthesis in MS patients by suppressing the differentiation of oligodendrocyte precursor cells and triggers neuro-immune dysregulation. In migraine and cluster headaches, decreased melatonin levels and weakened control of the suprachiasmatic nucleus increase the frequency of nocturnal attacks. Similarly, in neuropathic pain, the disruption of circadian rhythm enhances pain sensitivity by increasing glutamate concentration and stimulating the opioid nociceptive system. Consequently, circadian rhythm is a vital factor modulating the cellular and molecular processes of neurological diseases.
Referanslar
Rosenwasser AM, Turek FW. Neurobiology of Circadian Rhythm Regulation. Sleep Medicine Clinics. 2015;10(4):403-412. doi:10.1016/j.jsmc.2015.08.003
Zelinski EL, Deibel SH, McDonald RJ. The trouble with circadian clock dysfunction: multiple deleterious effects on the brain and body. Neuroscience and Biobehavioral Reviews. 2014;40:80-10. doi:10.1016/j.neubiorev.2014.01.007
2020 Alzheimer's disease facts and figures. Alzheimers Dement. 2020. doi:10.1002/alz.12068.
Homolak J, Mudrovčić M, Vukić B, et al. Circadian Rhythm and Alzheimer's Disease. Medical Sciences (Basel). 2018;6(3):52. doi:10.3390/medsci6030052
Kang JE, Lim MM, Bateman RJ, et al. Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science (New York, NY). 2009;326(5955):1005-1007. doi:10.1126/science.1180962
Kress BT, Iliff JJ, Xia M, et al. Impairment of paravascular clearance pathways in the aging brain. Annals of Neurology. 2014;76(6):845-861. doi: 10.1002/ana.24271
Coogan AN, Schutová B, Husung S, et al. The circadian system in Alzheimer's disease: disturbances, mechanisms, and opportunities. Biological Psychiatry. 2013;74(5):333-339. doi: 10.1016/j.biopsych.2012.11.021
Di Meco A, Joshi YB, Praticò D. Sleep deprivation impairs memory, tau metabolism, and synaptic integrity of a mouse model of Alzheimer's disease with plaques and tangles. Neurobiol Aging. 2014;35(8):1813-1820. doi: 10.1016/j.neurobiolaging.2014.02.011
Holth J, Patel T, Holtzman DM. Sleep in Alzheimer's Disease - Beyond Amyloid. Neurobiology of Sleep and Sircadian Rhythms. 2017;2:4-14. doi: 10.1016/j.nbscr.2016.08.002
Stevanovic K, Yunus A, Joly-Amado A, et al. Disruption of normal circadian clock function in a mouse model of tauopathy. Experimental Neurology. 2017;294:58-67. doi: 10.1016/j.expneurol.2017.04.015
Lim AS, Yu L, Kowgier M, Schneider JA,et l. Modification of the relationship of the apolipoprotein E ε4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep. JAMA Neurology. 2013;70(12):1544-1551. doi:10.1001/jamaneurol.2013.4215
Wu YH, Feenstra MG, Zhou JN, et al. Molecular changes underlying reduced pineal melatonin levels in Alzheimer disease: alterations in preclinical and clinical stages. The Journal of Clinical Endocrinology and Metabolism. 2003;88(12):5898-5906. doi: 10.1210/jc.2003-030833
Tholfsen LK, Larsen JP, Schulz J, et al. Development of excessive daytime sleepiness in early Parkinson disease. Neurology. 2015;85(2):162-168. doi: 10.1212/WNL.0000000000001737
Breen DP, Vuono R, Nawarathna U, et al. Sleep and circadian rhythm regulation in early Parkinson disease. JAMA Neurol 2014;71(5):589-595. doi: 10.1001/jamaneurol.2014.65
Bolitho SJ, Naismith SL, Rajaratnam SM, et al. Disturbances in melatonin secretion and circadian sleep-wake regulation in Parkinson disease. Sleep Med. 2014;15(3):342-347. doi: 10.1016/j.sleep.2013.10.016
Berganzo K, Diez-Arrola B, Tijero B, et al. Nocturnal hypertension and dysautonomia in patients with Parkinson’s disease: Are they related?. J Neurol. 2013;260(7):1752-1756. doi: 10.1007/s00415-013-6859-5
Bordet R, Devos D, Brique S, et al. Study of circadian melatonin secretion pattern at different stages of Parkinson’s disease. Clin Neuropharmacol. 2003;26(2):65-72. doi: 10.1097/00002826-200303000-00005
Dong H, Wang J, Yang YF, et al. Dorsal striatum dopamine levels fluctuate across the sleep–wake cycle and respond to salient stimuli in mice. Frontiers in Neuroscience. 2019;13:242. doi: 10.3389/fnins.2019.00242
Baumann CR, Kilic E, Petit B, et al. Sleep EEG changes after middle cerebral artery infarcts in mice: different effects of striatal and cortical lesions. Sleep. 2006;29(10):1339-1344. doi: 10.1093/sleep/29.10.1339
Babu CS, Ramanathan M. Post-ischemic administration of nimodipine following focal cerebral ischemic-reperfusion injury in rats alleviated excitotoxicity, neurobehavioural alterations and partially the bioenergetics. International Journal of Developmental Neuroscience. 2011;29(1):93-105. doi: 10.1016/j.ijdevneu.2010.08.001
Dinges DF, Douglas SD, Hamarman S, et al. Sleep deprivation and human immune function. Advances in Neuroimmunology. 1995;5(2):97-110. doi: 10.1016/0960-5428(95)00002-j
Gao B, Kilic E, Baumann CR, et al. Gamma-hydroxybutyrate accelerates functional recovery after focal cerebral ischemia. Cerebrovascular Diseases. 2008;26(4):413-419. doi: 10.1159/000151683
Lanigar S, Bandyopadhyay S. Sleep and epilepsy: a complex interplay. Missouri Medicine. 2017;114(6):453-457.
Staniszewska A, Mąka A, Religioni U, et al. Sleep disturbances among patients with epilepsy. Neuropsychiatric Disease and Treatment. 2017;13:1797-1803. doi: 10.2147/NDT.S136868
Bialasiewicz P, Nowak D. Obstructive sleep apnea syndrome and nocturnal epilepsy with tonic seizures. Epileptic Disorders. 2009;11(4):320-323. doi: 10.1684/epd.2009.0277
Degen R, Degen HE. A comparative study of the diagnostic value of drug-induced sleep EEGs and sleep EEGs following sleep deprivation in patients with complex partial seizures. Journal of Neurology. 1981;225(2):85-93. doi: 10.1007/BF00313322
Kotagal P. The relationship between sleep and epilepsy. Seminars in Pediatric Neurology. 2001;8(4):241-250. doi: 10.1053/spen.2001.29476
Jain SV, Glauser TA. Effects of epilepsy treatments on sleep architecture and daytime sleepiness: an evidence-based review of objective sleep metrics. Epilepsia. 2014;55(1):26-37. doi: 10.1111/epi.12478
Kaminska M, Kimoff RJ, Schwartzman K, et al. Sleep disorders and fatigue in multiple sclerosis: evidence for association and interaction. Journal of the Neurological Sciences. 2021;302(1-2):7-13. doi: 10.1016/j.jns.2010.12.008
Papantoniou K, Massa J, Devore E, et al. Rotating night shift work and risk of multiple sclerosis in the Nurses’ Health Studies. Occupational and Environmental Medicine. 2019;76(10):733-738. doi: 10.1136/oemed-2019-106016
Chalah MA, Ayache SS. Is there a link between inflammation and fatigue in multiple sclerosis?. Journal of Inflammation Research. 2018;11:253-264. doi: 10.2147/JIR.S167199. eCollection 2018
Bellesi M, Pfister-Genskow M, Maret S, et al. Effects of sleep and wake on oligodendrocytes and their precursors. Journal of Neuroscience. 2013;33(36):14288-14300. doi: 10.1523/JNEUROSCI.5102-12.2013
Loddenkemper T, Lockley SW, Kaleyias J, et al. Chronobiology of epilepsy: Diagnostic and therapeutic implications of chrono-epileptology. J Clin Neurophysiol. 2011;28(2):146-153. doi: 10.1097/WNP.0b013e31821213d4
Maasumi K, Tepper SJ, Kriegler JS. Menstrual migraine and treatment options. Review Headache. 2017;57(2):194-208. doi: 10.1111/head.12978. Epub 2016 Dec 2.
Kelman L, Rains JC. Headache and sleep: Examination of sleep patterns and complaints in a large clinical sample of migraineurs. Headache. 2005;45(7):904-910. doi: 10.1111/j.1526-4610.2005.05159.x
Hougaard A, Amin FM, Hauge AW, et al. Provocation of migraine with aura using natural trigger factors. Neurology. 2013;81(23):2057. doi: 10.1212/01.wnl.0000440604.28014.b3
Noseda R, Copenhagen D, Burstein R. Current understanding of photophobia, visual networks and headaches. Cephalalgia. 2019;39(13):1623-1634. doi: 10.1177/0333102418784750
Pandi-Perumal SR, Trakht I, Srinivasan V, et al. Physiological effects of melatonin: Role of melatonin receptors and signal transduction pathways. Prog Neurobiol. 2008;85(3):335-353. doi: 10.1016/j.pneurobio.2008.04.001
Peres MFP, Valença MM, Amaral FG, et al. Current understanding of pineal gland structure and function in headache. Cephalalgia. 2019;39(13):1700-1709. doi: 10.1177/0333102419868187
Liampas I, Siokas V, Brotis A, et al. Endogenous melatonin ievels and therapeutic use of exogenous melatonin in migraine: Systematic Review and Meta-Analysis. Headache.2020; 60(7):1273-1299. doi: 10.1111/head.13828
van Oosterhout WPJ, van Someren EJW, Schoonman GG, et al. Chronotypes and circadian timing in migraine. Cephalalgia. 2018;38(4):617-625. doi: 10.1177/0333102417698953
Marmura MJ. Triggers, protectors, and predictors in episodic Mmigraine. Curr Pain Headache Rep. 2018;22(12):81. doi: 10.1007/s11916-018-0734-0
Bertisch SM, Li W, Buettner C, et al. Nightly sleep duration, fragmentation, and quality and daily risk of migraine. Neurology. 2020;94(5):e489-e496. doi: 10.1212/WNL.0000000000008740
Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1-211. doi: 10.1177/0333102417738202
Lund N, Westergaard ML, Barloese M, et al. Epidemiology of concurrent headache and sleep problems in Denmark. Cephalalgia. 2014;34(10):833-845. doi: 10.1177/0333102414543332
Pfaffenrath V, Pöllmann W, Rüther E, et al. Onset of nocturnal attacks of chronic cluster headache in relation to sleep stages. Acta Neurol Scand. 1986;73(4):403-407. doi: 10.1111/j.1600-0404.1986.tb03296.x
Lund N, Barloese M, Petersen A, et al. Chronobiology differs between men and women with cluster headache, clinical phenotype does not. Neurology. 2017;88 (11):1069-1076. doi: 10.1212/WNL.0000000000003715.
Kudrow L. The cyclic relationship of natural illumination to cluster period frequency. Cephalalgia. 1987;7(6):76-78. doi: 10.1177/03331024870070S623
Hagen EM, Rekand T. Management of neuropathic pain asociated with spinal cord injury. Pain and Therapy. 2015;4(1):51-65. doi: 10.1007/s40122-015-0033-y
Kundermann B, Krieg JC, Schreiber W, et al. The effect of sleep deprivation on pain. Pain Research and Management.2004;9(1):25-32. doi: 10.1155/2004/949187
Liu J, Clough SJ, Hutchinson AJ, et al. MT1 and MT2 melatonin receptors: a therapeutic perspective. Annual Review of Pharmacology and Toxicology. 2016;56(1):361-383. doi: 10.1146/annurev-pharmtox-010814-124742
Priya S, Mahalakshmi AM, Tuladhar S, et al. Sleep and body fluids. International Journal of Nutrition, Pharmacology, Neurological Diseases. 2020;10(2):65-68.
